What is the recommended treatment for gonorrhea in a patient with a penicillin allergy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Gonorrhea Treatment in Patients with Penicillin Allergy

For patients with penicillin allergy requiring gonorrhea treatment, use ceftriaxone 250 mg intramuscularly as a single dose plus azithromycin 1 g orally, as cephalosporins can be safely administered to most penicillin-allergic patients due to low cross-reactivity (approximately 1-3%). 1, 2

Primary Treatment Approach

The standard gonorrhea regimen remains appropriate for most penicillin-allergic patients because:

  • Ceftriaxone is a cephalosporin, not a penicillin, and true cross-reactivity between penicillins and third-generation cephalosporins is rare 3
  • The recommended regimen is ceftriaxone 125-250 mg intramuscularly plus azithromycin 1 g orally as a single dose 3, 1
  • This dual therapy addresses both gonorrhea and presumptive chlamydial co-infection 3, 2

For Severe Cephalosporin Allergy

If the patient has a documented severe cephalosporin allergy or anaphylaxis to beta-lactams:

Use azithromycin 2 g orally as a single dose 1, 2

Critical Requirements with Azithromycin Monotherapy:

  • Perform test-of-cure 1 week after treatment using culture (preferred) or NAAT 1, 2
  • Culture is preferred because it allows antimicrobial susceptibility testing 1, 2
  • Consult an infectious disease specialist due to limited data on alternative regimens 2
  • Report suspected treatment failures to local public health officials within 24 hours 1, 2

Important Caveats About Azithromycin:

  • Gastrointestinal adverse events are common with the 2 g dose 4
  • Resistance concerns exist, particularly in certain geographic areas 5
  • Azithromycin 1 g is insufficient as monotherapy and should not be used 3

Additional Alternative Regimens

For uncomplicated urogenital and anorectal infections when cephalosporins cannot be used:

  • Spectinomycin 2 g intramuscularly as a single dose (cure rate 98.2%) 1
  • Gentamicin 240 mg intramuscularly plus azithromycin 2 g orally (100% cure rate in clinical trials) 4
  • Gemifloxacin 320 mg orally plus azithromycin 2 g orally (99.5% cure rate) 4

Critical Limitation of Spectinomycin:

  • Only 52% effective against pharyngeal gonorrhea 3, 1
  • Requires pharyngeal culture 3-5 days post-treatment if pharyngeal infection suspected 3

Quinolone Considerations

Quinolones should NOT be routinely used due to widespread resistance 3

Only consider quinolones if:

  • Antimicrobial susceptibility testing confirms susceptibility 1
  • Options include ciprofloxacin 500 mg orally or levofloxacin 250 mg orally 3

Site-Specific Treatment Considerations

Pharyngeal Gonorrhea:

  • More difficult to eradicate than urogenital infections 3, 1
  • Ceftriaxone remains most effective 3
  • Spectinomycin is inadequate (52% efficacy) 3, 1
  • Gentamicin/azithromycin cured 10/10 pharyngeal infections in trials 4
  • Gemifloxacin/azithromycin cured 15/15 pharyngeal infections 4

Disseminated Gonococcal Infection:

  • Ceftriaxone 1 g IM/IV daily for ≥1 week 3
  • Alternative: Spectinomycin 2 g IM every 12 hours for ≥1 week 3

Gonococcal Conjunctivitis:

  • Ceftriaxone 1 g intramuscularly as single dose 3
  • Consider saline lavage of infected eye 3

Essential Management Steps

Partner Management:

  • Evaluate and treat all sex partners from preceding 60 days 1, 2
  • Patients must avoid sexual intercourse until therapy completed and both partners asymptomatic 1, 2
  • Consider expedited partner therapy if partner treatment cannot be ensured 2

Co-infection Treatment:

  • Always treat presumptively for chlamydia unless ruled out 3, 2
  • Use azithromycin 1 g orally or doxycycline 100 mg orally twice daily for 7 days 3

Follow-up Testing:

  • Test-of-cure required only for alternative regimens (not standard ceftriaxone) 3
  • Retest all patients at 3 months due to high reinfection rates 3
  • If 3-month follow-up unlikely, retest whenever patient returns within 12 months 3

Special Populations

Pregnancy:

  • Pregnant women with penicillin allergy should receive ceftriaxone (cross-reactivity risk is acceptable) 3
  • Spectinomycin 2 g intramuscularly is alternative if cephalosporin absolutely contraindicated 3
  • Never use doxycycline, quinolones, or tetracyclines in pregnancy 3, 2
  • For chlamydia co-treatment: use erythromycin or amoxicillin 3, 2

HIV-Infected Patients:

  • Use same treatment regimens as HIV-negative patients 3
  • Exercise caution with alternative regimens as data are limited 3

Common Pitfalls to Avoid

  • Do not assume penicillin allergy precludes cephalosporin use—most patients can safely receive ceftriaxone 1, 2
  • Do not use azithromycin 1 g as monotherapy—insufficient efficacy 3
  • Do not use quinolones without susceptibility testing—resistance is widespread 3, 1
  • Do not forget test-of-cure with alternative regimens—treatment failure monitoring is essential 1, 2
  • Do not neglect chlamydia co-treatment—co-infection rates are high 3, 2

References

Guideline

Alternative Treatment Options for Gonorrhea and Chlamydia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment for Gonorrhea in Patients Allergic to Ceftriaxone

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.